Back to search
Reversal of Coagulopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Reversal of Coagulopathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Reversal of Coagulopathy trials you may qualify forThe aim of this study is to find out the effects of TAK-330 compared with four-factor prothrombin complex concentrate (4F-PCC) as part of standard treatment oth…
Post marketing observational study on safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Su…
The goal of this study is to determine if a fixed dose of 4-factor prothrombin complex concentrate (4FPCC) is as effective as the current standard of care. 4FPC…
To demonstrate that the efficacy of OCTAPLEX as a reversal agent in patients under Vitamin K Antagonist (VKA) therapy with the need for urgent surgery with sign…